Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / *W EXP 09/01/203
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
2,705,418
-
Shares change
-
+366,514
-
Total reported value, excl. options
-
$2,337,889
-
Value change
-
+$320,116
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$0.8750
Significant Holders of Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) as of Q2 2025
30 filings reported holding OACCW - Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 as of Q2 2025.
Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,705,418 shares
.
Largest 10 shareholders include AQR Arbitrage LLC (396,057 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (340,000 shares), Decagon Asset Management LLP (184,747 shares), Driehaus Capital Management LLC (180,000 shares), Walleye Capital LLC (169,802 shares), Boussard & Gavaudan Investment Management LLP (150,000 shares), Linden Advisors LP (120,000 shares), Shaolin Capital Management LLC (115,000 shares), MOORE CAPITAL MANAGEMENT, LP (105,000 shares), and Alberta Investment Management Corp (100,000 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.